🇺🇸 FDA
Pipeline program

Valbenazine

NBI-98854-TD4002

Approved small_molecule completed

Quick answer

Valbenazine for Tardive Dyskinesia (TD) is a Approved program (small_molecule) at NEUROCRINE BIOSCIENCES INC with 2 ClinicalTrials.gov record(s).

Program details

Company
NEUROCRINE BIOSCIENCES INC
Indication
Tardive Dyskinesia (TD)
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials